Millions taking common blood pressure medication at risk of deadly kidney disease, top experts warn
A study found that type 2 diabetes patients taking dihydropyridine calcium-channel blockers (DCCBs) were at a 33 per cent higher risk of complications like kidney disease.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.dailymail.co.uk — the content belongs to Daily Mail Health.